ATP2A2 encodes SERCA2 (Sarco/Endoplasmic Reticulum Calcium ATPase 2), a critical calcium pump that transports calcium from the cytosol into the endoplasmic reticulum (ER)[1]. This protein is essential for maintaining cellular calcium homeostasis, a fundamental process for neuronal function and survival. SERCA2 plays vital roles in ER calcium storage, protein folding, cellular signaling, and synaptic transmission.
The ATP2A2 gene is located on chromosome 12q24.11 and produces multiple isoforms through alternative splicing. SERCA2a is predominantly expressed in cardiac and skeletal muscle, while SERCA2b is the ubiquitous isoform found in all tissues including the brain. In neurons, SERCA2b is particularly important for maintaining ER calcium stores that are essential for cellular signaling, protein quality control, and synaptic function[@giacomomello2019].
Dysregulation of SERCA2 function has been implicated in multiple neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease[2]. Additionally, mutations in ATP2A2 cause Darier disease, an autosomal dominant skin disorder often accompanied by neuropsychiatric manifestations.
SERCA2 is a P-type ATPase that actively transports calcium ions from the cytosol into the ER lumen using ATP hydrolysis[1:1]. This process is crucial for:
The ATP2A2 gene produces multiple protein isoforms through alternative splicing:
The neuronal isoforms are predominantly SERCA2b, which has higher apparent affinity for calcium and is regulated by phospholamban (PLN) in some cell types.
SERCA2 activity is regulated at multiple levels:
SERCA2 dysfunction is increasingly recognized as an important contributor to Alzheimer's disease pathogenesis[3][4]:
Calcium Dysregulation:
ER Stress:
Tau Pathology:
Calcium dysregulation is a hallmark of PD pathogenesis[5]:
Neuronal Vulnerability:
Alpha-Synuclein Toxicity:
Mechanisms:
SERCA2 dysfunction has been implicated in:
Loss of SERCA2 function leads to[6]:
ER calcium depletion triggers the unfolded protein response (UPR)[7]:
Chronic UPR activation leads to apoptosis through CHOP-mediated cell death.
In neurons, SERCA2 is critical for[8]:
ER-mitochondrial calcium transfer is disrupted[9]:
ER calcium is essential for[10]:
ATP2A2 mutations cause Darier disease (keratosis follicularis), an autosomal dominant disorder:
Targeting SERCA2 represents a therapeutic strategy for neurodegeneration[11]:
ATP2A2 shows widespread expression:
In the brain, SERCA2 is localized to:
| Protein | Interaction Type | Functional Consequence |
|---|---|---|
| Phospholamban (PLN) | Regulatory binding | Inhibits SERCA2 activity |
| Calmodulin | Calcium sensing | Modulates activity |
| IP3 Receptor | Calcium release | Provides calcium for uptake |
| Ryanodine Receptor | Calcium release | Provides calcium for uptake |
| BiP/GRP78 | ER chaperone | Protein folding cofactor |
| Calreticulin | ER calcium binding | ER calcium storage |
| Disease | Association | Mechanism |
|---|---|---|
| Alzheimer's Disease | Risk factor | ER calcium depletion, tau pathology |
| Parkinson's Disease | Risk factor | Synaptic calcium dysregulation |
| Huntington's Disease | Risk factor | ER stress, mitochondrial dysfunction |
| Darier Disease | Causative | ATP2A2 mutations |
| ALS | Risk factor | Calcium dysregulation in motor neurons |
Calcium signaling and ER stress. Trends in Pharmacological Sciences. 2020. ↩︎ ↩︎
SERCA and neurodegeneration. Cell Calcium. 2019. ↩︎
Calcium homeostasis in Alzheimer's disease. Nature Reviews Neuroscience. 2022. ↩︎
Tau pathology and calcium signaling disruption. Acta Neuropathologica. 2024. ↩︎
Calcium dysregulation in Parkinson's disease. Movement Disorders. 2023. ↩︎
Calcium store depletion in neurodegeneration. Neuropharmacology. 2020. ↩︎
ER stress in neurodegenerative diseases. Cell Death and Disease. 2023. ↩︎
ER calcium signaling in synaptic transmission. Neuron. 2024. ↩︎
Mitochondrial calcium handling in neurodegeneration. Cell Metabolism. 2023. ↩︎
ER-associated degradation in neurodegeneration. Trends in Biochemical Sciences. 2024. ↩︎
SERCA modulators in neurological disorders. Pharmacological Reviews. 2024. ↩︎